Retrospective analysis of sorafenib efficacy and safety in Chinese patients with high recurrence rate of post-hepatic carcinectomy
Desheng Wang,1,*, Weridong Jia,2,*, Zhiming Wang,3 Tianfu Wen,4 Wei Ding,5 Feng Xia,6 Ling Zhang,7 Feixiang Wu,8 Tao Peng,9 Bin Liu,10 Cuncai Zhou,11 Qichang Zheng,12 Xiongying Miao,13 Junping Peng,14 Zhiyong Huang,15 Kefeng Dou11Department of Hepatobiliary Surgery, Xijing Hospital, Shaanxi, China;...
Main Authors: | Wang D, Jia W, Wang Z, Wen T, Ding W, Xia F, Zhang L, Wu F, Peng T, Liu B, Zhou C, Zheng Q, Miao X, Peng J, Huang Z, Dou K |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-07-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/retrospective-analysis-of-sorafenib-efficacy-and-safety-in-chinese-pat-peer-reviewed-article-OTT |
Similar Items
-
Association Between Adjuvant Sorafenib and the Prognosis of Patients With Hepatocellular Carcinoma at a High Risk of Recurrence After Radical Resection
by: Qingli Li, et al.
Published: (2021-09-01) -
Efficacy and safety of sorafenib versus apatinib in the treatment of intermediate and advanced hepatocellular carcinoma: a comparative retrospective study
by: Wang Y, et al.
Published: (2018-06-01) -
Clinical impact of lenvatinib in patients with unresectable hepatocellular carcinoma who received sorafenib
by: Yen-Yang Chen, et al.
Published: (2020-11-01) -
Transarterial Chemoembolization Combined with Sorafenib in Patients with BCLC Stage C Hepatocellular Carcinoma
by: Liu KC, et al.
Published: (2020-08-01) -
Diffuse Recurrence of Hepatocellular Carcinoma After Liver Resection: Transarterial Chemoembolization (TACE) Combined With Sorafenib Versus TACE Monotherapy
by: Wang Yao, et al.
Published: (2020-12-01)